Gainers
- Biophytis S.A. BPTS shares jumped 114% to $0.7496.
- Corbus Pharmaceuticals Holdings, Inc. CRBP rose 74.1% to $0.2115.
- Myomo, Inc. MYO shares rose 40.4% to $0.8551. Myomo recently posted upbeat quarterly results.
- Edible Garden AG Incorporated EDBL gained 37.7% to $0.42.
- XPeng Inc. XPEV shares surged 36.2% to $10.00 after the company reported Q3 earnings and delivery results and issued Q4 sales and delivery guidance.
- Qutoutiao Inc. QTT gained 31.8% to $0.4787.
- Vapotherm, Inc. VAPO rose 28.6% to $0.8490 after declining around 10% on Tuesday.
- Horizon Therapeutics Public Limited Company HZNP shares jumped 27.7% to $100.59 after the company confirmed preliminary discussions regarding a potential offer. The company is in discussions with Amgen, Janssen and Sanofi.
- Otonomy, Inc. OTIC rose 27.3% to $0.2914 after jumping around 114% on Tuesday. The company recently posted a quarterly loss of $0.18 per share.
- Check-Cap Ltd. CHEK surged 26.7% to $3.73. Check-Cap reported a Q3 net loss of $4.7 million.
- Satixfy Communications Ltd. SATX gained 23.5% to $19.00.
- Uxin Limited UXIN gained 21% to $2.6884.
- Agora, Inc. API climbed 20.8% to $3.2016.
- Immunome, Inc. IMNM climbed 19.8% to $4.4683. Immunome recently posted a Q3 loss of $0.75 per share.
- NIO Inc. NIO gained 19.8% to $12.58 in sympathy with Xpeng after the company reported Q3 earnings and delivery results and issued Q4 guidance.
- Kingsoft Cloud Holdings Limited KC surged 17.7% to $2.99.
- Atour Lifestyle Holdings Limited ATAT gained 17.4% to $14.97.
- Li Auto Inc. LI jumped 16.6% to $21.61 in sympathy with XPeng, which gained after the company reported Q3 earnings and delivery results and issued Q4 sales and delivery guidance.
- Dada Nexus Limited DADA climbed 16.5% to $6.59.
- GDS Holdings Limited GDS gained 16.3% to $15.69.
- Eargo, Inc. EAR gained 16% to $0.6201 after the company was granted US Patent #11516601: Hearing assistance device with an accelerometer.
- Build-A-Bear Workshop, Inc. BBW surged 16% to $22.48 after the company reported Q3 EPS results were higher year over year and better-than-expected Q3 sales results. The company also raised FY22 total revenue guidance.
- Titan Machinery Inc. TITN gained 13.8% to $39.70 after the company reported better-than-expected Q3 adjusted EPS and sales results.
- WaveDancer, Inc. WAVD jumped 13% to $0.6099.
- Viridian Therapeutics, Inc. VRDN rose 12.5% to $25.75. The company recently posted upbeat quarterly results.
- Dingdong (Cayman) Limited DDL surged 12.2% to $4.3550.
- Mesoblast Limited MESO gained 11.8% to $3.58. The company recently posted upbeat quarterly earnings.
- Workday, Inc. WDAY gained 11.7% to $160.13 after the company reported better-than-expected Q3 EPS and sales results. The company also raised its FY23 subscription revenue guidance and announced a buyback of up to $500 million.
- BeiGene, Ltd. BGNE rose 11.5% to $200.47.
- Titan Medical Inc. TMDI gained 10.7% to $0.4399. Titan Medical announced commencement of strategic review process.
- Ontrak, Inc. OTRK gained 9.2% to $0.44.
- Lufax Holding Ltd LU rose 8.7% to $11.75 after surging 14% on Tuesday. Share of Chinese companies traded higher amid reopening hopes after Guangzhou reportedly relaxed restrictions in some districts. China has also aimed to boost vaccination efforts to avoid further lockdowns.
- Tuniu Corporation TOUR rose 6.9% to $1.09. Tuniu is expected to report Q3 financial results on December 1, 2022.
- Zhihu Inc. ZH rose 4.8% to $1.0999 after reporting strong quarterly results.
Losers
- Aeglea BioTherapeutics, Inc. AGLE shares dropped 59.7% to $0.4920 after the company announced it no longer plans to announce interim clinical data from the ongoing Phase 1/2 clinical trial of pegtarviliase in Classical Homocystinuria in Q4 2022.
- Pacifico Acquisition Corp. PAFO fell 41.8% to $5.51.
- Starwood Waypoint Homes of Ben SFR shares fell 37.9% to $6.68.
- WiSA Technologies, Inc. WISA dropped 33% to $0.1106. WiSA Technologies announced pricing of $7.6 million public offering of 50.4 million units at a price of $0.14 per unit.
- CN Energy Group. Inc. CNEY shares fell 32.7% to $0.9955 after dropping 14% on Tuesday.
- OncoSec Medical Incorporated ONCS fell 23.8% to $2.9351. OncoSec reported pricing of $3.5 million public offering.
- Solid Power, Inc. SLDP dropped 23.6% to $3.2788 after the company reported CEO transition. DA Davidson downgraded the stock from Buy to Neutral and lowered its price target from $13 to $5.
- Cosmos Holdings Inc. COSM fell 23.6% to $0.59 after surging 33% on Tuesday. Cosmos Health entered into development phase for CCX0722.
- Oncorus, Inc. ONCR dipped 23.2% to $0.47. Oncorus is reprioritizing its pipeline and is discontinuing the Phase 1 trial of ONCR-177 to focus resources on ONCR-021.
- Tuesday Morning Corporation TUEM shares fell 22.2% to $0.1192. Tuesday Morning reported a 1-for-30 reverse stock split.
- Helbiz, Inc. HLBZ fell 20.4% to $0.2300 after gaining 6% on Tuesday.
- CrowdStrike Holdings, Inc. CRWD fell 19.4% to $111.19 after the company issued Q4 sales guidance below analyst estimates.
- NanoVibronix, Inc. NAOV fell 19.1% to $0.4045 after the company announced a $2.4 million registered direct offering priced at-the-market under Nasdaq rules.
- Troika Media Group, Inc. TRKA dipped 17.8% to $0.1289.
- Cango Inc. CANG fell 17.7% to $1.25 following wider-than-expected quarterly loss.
- Science 37 Holdings, Inc. SNCE dipped 14.5% to $0.57.
- Offerpad Solutions Inc. OPAD fell 13.7% to $0.7103.
- MillerKnoll, Inc. MLKN dropped 13% to $19.45 after Benchmark downgraded the stock from Buy to Hold.
- EUDA Health Holdings Limited EUDA shares fell 12% to $2.80 after gaining 4% on Tuesday.
- Leonardo DRS, Inc. DRS fell 11.1% to $9.77. Vertical Research initiated coverage on Leonardo DRS with a Buy rating and announced a price target of $14.
- SentinelOne, Inc. S dropped 10.6% to $13.80. Shares of cybersecurity companies traded lower following soft Q4 revenue guidance from CrowdStrike.
- Leslie's, Inc. LESL dropped 9.4% to $13.64 after the company reported Q4 earnings results.
- Steelcase Inc. SCS fell 9.3% to $7.45 after Benchmark downgraded the stock from Buy to Hold.
- X4 Pharmaceuticals, Inc. XFOR shares fell 8.7% to $1.69 after the company reported top-line results from 4WHIM global, pivotal Phase 3 trial of once-daily, oral mavorixafor in WHIM syndrome.
- NetApp, Inc. NTAP shares fell 7.8% to $66.18 after the company reported worse-than-expected Q2 sales results and issued weak FY23 guidance.
- Zscaler, Inc. ZS fell 7.6% to $124.58. Shares of cybersecurity companies traded lower following soft Q4 revenue guidance from CrowdStrike.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in